Fennec Pharmaceuticals Inc. (TSX:FRX)
Canada · Delayed Price · Currency is CAD 13.29
0.00 (0.00%)
Nov 5, 2026, 3:33 PM EST
Fennec Pharmaceuticals Market Cap
Fennec Pharmaceuticals has a market cap or net worth of CAD 484.97 million as of November 9, 2026. Its market cap has increased by 49.55% in one year.
Market Cap
484.97M
Enterprise Value
426.82M
Revenue
84.10M
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since November 12, 2004, Fennec Pharmaceuticals's market cap has increased from 89.84M to 484.97M, an increase of 439.84%. That is a compound annual growth rate of 7.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 484.97M | 34.50% |
| Dec 31, 2025 | 360.58M | 44.35% |
| Dec 31, 2024 | 249.80M | -36.88% |
| Dec 29, 2023 | 395.77M | 15.99% |
| Dec 30, 2022 | 341.20M | 135.62% |
| Dec 31, 2021 | 144.81M | -40.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 639.95M |
| Bright Minds Biosciences | 256.47M |
| Satellos Bioscience | 214.71M |
| Eastwood Bio-Medical Canada | 123.99M |
| Helix BioPharma | 68.74M |
| BriaCell Therapeutics | 48.64M |
| NurExone Biologic | 48.20M |
| Thiogenesis Therapeutics | 44.79M |